199 related articles for article (PubMed ID: 34627251)
41. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP
Borchmann P; Haverkamp H; Lohri A; Mey U; Kreissl S; Greil R; Markova J; Feuring-Buske M; Meissner J; Dührsen U; Ostermann H; Keller U; Maschmeyer G; Kuhnert G; Dietlein M; Kobe C; Eich H; Baues C; Stein H; Fuchs M; Diehl V; Engert A
Lancet Oncol; 2017 Apr; 18(4):454-463. PubMed ID: 28236583
[TBL] [Abstract][Full Text] [Related]
42. [Analysis of clinical characteristics and prognostic factors in patients with non-Hodgkin lymphoma and HBV infection].
Zhang L; Yuan XL; Jiang L; Yang J; Guo JM; Shi J; Lei PC; Zhang Y; Zhu ZM
Zhonghua Xue Ye Xue Za Zhi; 2018 Jul; 39(7):563-568. PubMed ID: 30122015
[No Abstract] [Full Text] [Related]
43. Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma.
Bonnet C; Beguin Y; Fassotte MF; Seidel L; Luyckx F; Fillet G
Eur J Haematol; 2007 May; 78(5):399-404. PubMed ID: 17419741
[TBL] [Abstract][Full Text] [Related]
44. Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection.
Su TH; Liu CJ; Tseng TC; Chou SW; Liu CH; Yang HC; Wu SJ; Chen PJ; Chen DS; Chen CL; Kao JH
Aliment Pharmacol Ther; 2019 Feb; 49(3):331-339. PubMed ID: 30592071
[TBL] [Abstract][Full Text] [Related]
45. The influence of rituximab-containing chemotherapy on HCV load in patients with HCV-associated non-Hodgkin's lymphomas.
Zhou X; Lisenko K; Lehners N; Egerer G; Ho AD; Witzens-Harig M
Ann Hematol; 2017 Sep; 96(9):1501-1507. PubMed ID: 28669008
[TBL] [Abstract][Full Text] [Related]
46. Efficacy and safety of chemotherapy or tyrosine kinase inhibitors combined with bevacizumab versus chemotherapy or tyrosine kinase inhibitors alone in the treatment of non-small cell lung cancer: a systematic review and meta-analysis.
Sun L; Ma JT; Zhang SL; Zou HW; Han CB
Med Oncol; 2015 Feb; 32(2):473. PubMed ID: 25603953
[TBL] [Abstract][Full Text] [Related]
47. Hepatitis C virus infection in non-Hodgkin's lymphoma.
King PD; Wilkes JD; Diaz-Arias AA
Clin Lab Haematol; 1998 Apr; 20(2):107-10. PubMed ID: 9681221
[TBL] [Abstract][Full Text] [Related]
48. Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis.
Qin K; Hou H; Liang Y; Zhang X
BMC Cancer; 2020 Apr; 20(1):328. PubMed ID: 32299384
[TBL] [Abstract][Full Text] [Related]
49. Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphoma.
Pellicelli AM; Marignani M; Zoli V; Romano M; Morrone A; Nosotti L; Barbaro G; Picardi A; Gentilucci UV; Remotti D; D'Ambrosio C; Furlan C; Mecenate F; Mazzoni E; Majolino I; Villani R; Andreoli A; Barbarini G
World J Hepatol; 2011 Nov; 3(11):278-84. PubMed ID: 22125661
[TBL] [Abstract][Full Text] [Related]
50. Predicting the outcome of Sjogren's syndrome-associated non-hodgkin's lymphoma patients.
Papageorgiou A; Ziogas DC; Mavragani CP; Zintzaras E; Tzioufas AG; Moutsopoulos HM; Voulgarelis M
PLoS One; 2015; 10(2):e0116189. PubMed ID: 25723713
[TBL] [Abstract][Full Text] [Related]
51. Benzene exposure increases the risk of non-Hodgkin's lymphoma: a systematic review and meta-analysis of observational studies.
Liu Y; Wang J
Transl Cancer Res; 2022 Jun; 11(6):1750-1761. PubMed ID: 35836544
[TBL] [Abstract][Full Text] [Related]
52. T-cell non-Hodgkin's lymphoma in adults: clinicopathological characteristics, response to treatment and prognostic factors.
Reiser M; Josting A; Soltani M; Staib P; Salzberger B; Diehl V; Engert A
Leuk Lymphoma; 2002 Apr; 43(4):805-11. PubMed ID: 12153168
[TBL] [Abstract][Full Text] [Related]
53. Comparative Efficacy and Safety of Biosimilar Rituximab and Originator Rituximab in Rheumatoid Arthritis and Non-Hodgkin's Lymphoma: A Systematic Review and Meta-analysis.
Lee S; Lee H; Kim E
BioDrugs; 2019 Oct; 33(5):469-483. PubMed ID: 31446557
[TBL] [Abstract][Full Text] [Related]
54. Aldehyde dehydrogenase serves as a biomarker for worse survival profiles in ovarian cancer patients: an updated meta-analysis.
Xia Y; Wei X; Gong H; Ni Y
BMC Womens Health; 2018 Dec; 18(1):199. PubMed ID: 30522488
[TBL] [Abstract][Full Text] [Related]
55. Hepatitis C virus and non-Hodgkin's lymphomas: A minireview.
Khaled H; Abu-Taleb F; Haggag R
J Adv Res; 2017 Mar; 8(2):131-137. PubMed ID: 28149648
[TBL] [Abstract][Full Text] [Related]
56. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397
[TBL] [Abstract][Full Text] [Related]
57. Prognostic impact of hepatitis C virus infection in patients with diffuse large B-cell lymphoma treated with immunochemotherapy in the context of a novel prognostic index.
Chen YY; Huang CE; Liang FW; Lu CH; Chen PT; Lee KD; Chen CC
Cancer Epidemiol; 2015 Jun; 39(3):382-7. PubMed ID: 25899771
[TBL] [Abstract][Full Text] [Related]
58. Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2018 May; 480():166-172. PubMed ID: 29462592
[TBL] [Abstract][Full Text] [Related]
59. Hepatitis B and C virus infection in Romanian non-Hodgkin's lymphoma patients.
Cucuianu A; Patiu M; Duma M; Basarab C; Soritau O; Bojan A; Vasilache A; Mates M; Petrov L
Br J Haematol; 1999 Nov; 107(2):353-6. PubMed ID: 10583224
[TBL] [Abstract][Full Text] [Related]
60. Clinical features and outcome in HCV-positive aggressive non-Hodgkin's lymphoma.
Tomita N; Kodama F; Takabayashi M; Kawano T; Yamaji S; Fujimaki K; Fujisawa S; Kanamori H; Motomura S; Ishigatsubo Y
Leuk Lymphoma; 2003 Jul; 44(7):1159-64. PubMed ID: 12916868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
